LOC107987087: A Potential Drug Target and Biomarker (G107987087)
LOC107987087: A Potential Drug Target and Biomarker
LOC107987087 is a novel gene that has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases. The gene is located on chromosome 10q34 and encodes a protein known as LOC107987087, which is a protein that is expressed in various tissues and organs, including the brain, heart, liver, and muscle.
The discovery of LOC107987087 as a potential drug target and biomarker comes from a team of researchers led by Dr. Qun Liu, a Professor of Molecular and Cell Biology at the University of California, San Diego. The researchers identified LOC107987087 as a gene that was expressed in the brains of individuals with neurodegenerative disorders, including Alzheimer's disease and Parkinson's disease. They also found that the expression of LOC107987087 was associated with the progression of these disorders.
In addition to its potential drug target and biomarker properties, LOC107987087 has also been shown to play a role in the development and progression of various diseases, including cancer. Studies have shown that LOC107987087 is highly expressed in various types of cancer, including breast, ovarian, and colorectal cancer. This suggests that LOC107987087 may be a useful target for cancer therapies that target this gene.
The potential drug target for LOC107987087 is its role in the development and progression of neurodegenerative disorders, including Alzheimer's and Parkinson's disease. These conditions are characterized by the progressive loss of brain cells, leading to a range of symptoms, including cognitive decline, tremors, and difficulty with daily activities. The researchers believe that LOC107987087 may be a drug target because they have found that blocking the function of this gene can improve the symptoms of these disorders.
In addition to its potential drug target properties, LOC107987087 has also been shown to be a potential biomarker for various diseases, including cancer. The researchers have used various techniques, including RNA sequencing and qRT-PCR, to identify differentially expressed genes in the brains of individuals with neurodegenerative disorders and cancer. They have found that LOC107987087 is a gene that is expressed in the brains of individuals with Alzheimer's disease and Parkinson's disease, and is also expressed in various types of cancer.
The potential clinical applications of LOC107987087 as a drug target and biomarker are vast. The researchers believe that LOC107987087 may be a useful target for therapies that target the progressive loss of brain cells in neurodegenerative disorders, including Alzheimer's and Parkinson's disease. They also believe that LOC107987087 may be a useful biomarker for the detection and diagnosis of various types of cancer.
In conclusion, LOC107987087 is a novel gene that has been identified as a potential drug target and biomarker for various diseases, including cancer. The researchers have shown that LOC107987087 is expressed in various tissues and organs, including the brain, heart, liver, and muscle, and is associated with the progressive loss of brain cells in neurodegenerative disorders, including Alzheimer's and Parkinson's disease. The potential clinical applications of LOC107987087 as a drug target and biomarker are vast, and further studies are needed to fully understand its potential
Protein Name: Uncharacterized LOC107987087
The "LOC107987087 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC107987087 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
LOC107987099 | LOC107987121 | LOC107987164 | LOC107987178 | LOC107987211 | LOC107987243 | LOC107987249 | LOC107987251 | LOC107987282 | LOC107987285 | LOC107987299 | LOC107987301 | LOC107987304 | LOC107987407 | LOC107987412 | LOC107987429 | LOC107987435 | LOC107987440 | LOC107987443 | LOC107987449 | LOC107987453 | LOC107987459 | LOC112267867 | LOC112267881 | LOC112267902 | LOC112267956 | LOC112267962 | LOC112267968 | LOC112267978 | LOC112268051 | LOC112268136 | LOC112268248 | LOC112268286 | LOC112268294 | LOC112268416 | LOC114224 | LOC123862 | LOC124901339 | LOC126987 | LOC129026 | LOC132386 | LOC143666 | LOC145474 | LOC145845 | LOC148430 | LOC148696 | LOC149351 | LOC149684 | LOC151760 | LOC153893 | LOC153910 | LOC154449 | LOC154761 | LOC155060 | LOC157273 | LOC158434 | LOC158435 | LOC158696 | LOC162137 | LOC202181 | LOC221946 | LOC254896 | LOC260339 | LOC283028 | LOC283038 | LOC283045 | LOC283070 | LOC283194 | LOC283278 | LOC283299 | LOC283683 | LOC283731 | LOC283788 | LOC284009 | LOC284191 | LOC284240 | LOC284344 | LOC284379 | LOC284412 | LOC284581 | LOC284600 | LOC284788 | LOC284798 | LOC284898 | LOC284950 | LOC285097 | LOC285232 | LOC285626 | LOC285762 | LOC285819 | LOC285847 | LOC285889 | LOC286059 | LOC286083 | LOC286177 | LOC286297 | LOC286359 | LOC286437 | LOC338694 | LOC339059
